| |
| |
|
| Insider
Information: |
Cox Troy |
| Relationship: |
Director |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
205,604 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$555,648 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
205,604 |
|
|
| Total
Value |
$555,648 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
0
|
|
Stock
price went up :
|
1
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
1.0
|
0.0
|
| Percentage
Gain/Loss : |
 1.9%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Foundation Medicine, Inc. |
FMI |
President and CEO, Dir... |
2018-07-31 |
0 |
2017-02-06 |
0 |
Premium* |
|
|
Zymeworks Inc |
ZYME |
Director |
2020-01-27 |
7,500 |
2020-01-27 |
0 |
Premium* |
|
|
Cm Life Sciences Ii Inc. |
SLGC |
Director |
2024-01-05 |
0 |
2021-09-01 |
0 |
Premium* |
|
|
Fluidigm Corp |
FLDM |
Director |
2024-01-05 |
198,104 |
2024-01-05 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
16 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| SLGC |
Cm Life Sciences Ii Inc. |
Director |
– • – |
2024-01-05 |
4 |
D |
$0.00 |
$0 |
D/D |
(78,430) |
0 |
0 |
- |
|
| FLDM |
Fluidigm Corp |
Director |
– • – |
2024-01-05 |
4 |
A |
$0.00 |
$0 |
D/D |
198,104 |
198,104 |
0 |
- |
|
| SLGC |
Cm Life Sciences Ii Inc. |
Executive Chair |
• • – |
2023-03-17 |
4 |
A |
$0.00 |
$0 |
D/D |
28,500 |
106,930 |
0 |
- |
|
| SLGC |
Cm Life Sciences Ii Inc. |
Director |
– • – |
2022-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
3,430 |
78,430 |
0 |
- |
|
| SLGC |
Cm Life Sciences Ii Inc. |
Director |
– • – |
2021-09-01 |
4 |
A |
$10.00 |
$500,000 |
D/D |
50,000 |
75,000 |
0 |
- |
|
| SLGC |
Cm Life Sciences Ii Inc. |
Director |
– • – |
2021-09-01 |
4 |
A |
$0.00 |
$0 |
D/D |
25,000 |
25,000 |
0 |
- |
|
| ZYME |
Zymeworks Inc |
Director |
– • – |
2020-01-27 |
4 |
B |
$46.50 |
$348,750 |
D/D |
7,500 |
7,500 |
2.39 |
% |
|
| FMI |
Foundation Medicine, Inc. |
President and CEO |
• • – |
2018-07-31 |
4 |
D |
$137.00 |
$28,338,039 |
D/D |
(206,847) |
0 |
0 |
- |
|
| FMI |
Foundation Medicine, Inc. |
President and CEO |
• • – |
2018-07-31 |
4 |
D |
$137.00 |
$4,825,277 |
D/D |
(35,221) |
206,847 |
0 |
- |
|
| FMI |
Foundation Medicine, Inc. |
Chief Executive Officer |
• • – |
2018-07-02 |
4 |
S |
$136.66 |
$191,597 |
D/D |
(1,402) |
242,068 |
0 |
- |
|
| FMI |
Foundation Medicine, Inc. |
Chief Executive Officer |
• • – |
2018-05-16 |
4 |
AS |
$77.10 |
$166,305 |
D/D |
(2,157) |
243,470 |
0 |
- |
|
| FMI |
Foundation Medicine, Inc. |
Chief Executive Officer |
• • – |
2018-05-07 |
4 |
S |
$70.01 |
$494,481 |
D/D |
(7,063) |
245,627 |
0 |
- |
|
| FMI |
Foundation Medicine, Inc. |
Chief Executive Officer |
• • – |
2018-04-01 |
4 |
A |
$78.75 |
$2,941,864 |
D/D |
37,357 |
252,690 |
0 |
- |
|
| FMI |
Foundation Medicine, Inc. |
Chief Executive Officer |
• • – |
2018-02-15 |
4 |
AS |
$67.22 |
$605,787 |
D/D |
(9,012) |
215,333 |
0 |
- |
|
| FMI |
Foundation Medicine, Inc. |
Chief Executive Officer |
• • – |
2018-02-07 |
4 |
S |
$70.13 |
$1,873,383 |
D/D |
(26,713) |
224,345 |
0 |
- |
|
| FMI |
Foundation Medicine, Inc. |
Chief Executive Officer |
• • – |
2017-02-06 |
4 |
A |
$18.92 |
$4,750,017 |
D/D |
251,058 |
251,058 |
0 |
- |
|
16 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
